1. Home
  2. RGEN vs INGR Comparison

RGEN vs INGR Comparison

Compare RGEN & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • INGR
  • Stock Information
  • Founded
  • RGEN 1981
  • INGR 1906
  • Country
  • RGEN United States
  • INGR United States
  • Employees
  • RGEN N/A
  • INGR N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • INGR Packaged Foods
  • Sector
  • RGEN Health Care
  • INGR Consumer Staples
  • Exchange
  • RGEN Nasdaq
  • INGR Nasdaq
  • Market Cap
  • RGEN 8.0B
  • INGR 8.4B
  • IPO Year
  • RGEN N/A
  • INGR 1997
  • Fundamental
  • Price
  • RGEN $131.55
  • INGR $137.72
  • Analyst Decision
  • RGEN Buy
  • INGR Hold
  • Analyst Count
  • RGEN 12
  • INGR 5
  • Target Price
  • RGEN $172.67
  • INGR $150.20
  • AVG Volume (30 Days)
  • RGEN 847.4K
  • INGR 429.5K
  • Earning Date
  • RGEN 04-29-2025
  • INGR 05-06-2025
  • Dividend Yield
  • RGEN N/A
  • INGR 2.31%
  • EPS Growth
  • RGEN N/A
  • INGR N/A
  • EPS
  • RGEN N/A
  • INGR 9.47
  • Revenue
  • RGEN $650,429,000.00
  • INGR $7,361,000,000.00
  • Revenue This Year
  • RGEN $13.93
  • INGR $3.18
  • Revenue Next Year
  • RGEN $14.35
  • INGR $2.60
  • P/E Ratio
  • RGEN N/A
  • INGR $14.61
  • Revenue Growth
  • RGEN 4.88
  • INGR N/A
  • 52 Week Low
  • RGEN $102.97
  • INGR $111.54
  • 52 Week High
  • RGEN $182.52
  • INGR $155.44
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 47.85
  • INGR 61.79
  • Support Level
  • RGEN $123.10
  • INGR $134.38
  • Resistance Level
  • RGEN $143.56
  • INGR $138.58
  • Average True Range (ATR)
  • RGEN 6.82
  • INGR 2.57
  • MACD
  • RGEN -0.65
  • INGR 0.70
  • Stochastic Oscillator
  • RGEN 33.43
  • INGR 73.84

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.

Share on Social Networks: